Introduction
Foot-and-mouth disease (FMD) is an infectious viral disease that affects cloven-hoofed animals, including cattle, sheep, pigs, goats, camelids and deer. Its wide host range and rapid spread make FMD an international animal health concern, since all countries are vulnerable to accidental or intentional trans-boundary introduction (Grubman and Baxt, 2004; Rowlands, 2003) . The disease is caused by foot-and-mouth disease virus (FMDV), an Aphthovirus within the viral family Picornaviridae that exists as seven immunologically distinct serotypes: O, A, C, Asia 1, and South African Territories (SAT) type 1, SAT2, and SAT3. The viral genome consists of a single-stranded, positive sense RNA of about 8200 nucleotides (nt) . The open reading frame (ORF) encodes a long polyprotein that is processed by virus-encoded proteases into four structural proteins (VP1 through 4) and eight non-structural proteins (L, 2A, 2B, 2C, 3A, 3B, 3C and 3D) (Belsham, 1993; Ryan et al., 1989) . Due to high error rates inherent in RNA replication, viral RNA genomes display a high level of nucleotide variation (Drake and Holland, 1999; Figlerowicz et al., 2003) that can affect replication speed (Jarousse et al., 1994; Nunez et al., 2001; Pelletier et al., 1998; Zhang et al., 1995) , virulence (Conenello et al., 2007; Zurbriggen et al., 1989) , antigenicity or biochemical properties MartinAcebes et al., 2010; Mateu et al., 1990; Szepanski et al., 1992) . The availability of infectious cDNA picornavirus clones provides an opportunity to manipulate specific genomic mutations and examine their effects on viral infection.
The genetic and antigenic variation has been extensively studied for FMDV both in field virus samples and laboratory cell-passed isolates (Carrillo et al., 2007; Cottam et al., 2009; Haydon et al., 2001; Meyer et al., 1994; Piatti et al., 1995; Sevilla et al., 1996) . For type O viruses selective pressures influence whether a histidine (H) or arginine (R) residue is present at position 56 of VP3. It has been reported that an R amino acid (aa) in position 56 of VP3 (R56) is acquired after serial passage in BHK-21 cells (Kitson et al., 1990; Marquardt et al., 1991) and that this mutation correlates with a small plaque phenotype, a marker indicative of virus attenuation in mice (Jensen and Moore, 1993) . Indeed, Sa-Carvalho et al. (Sa-Carvalho et al., 1997) constructed a type A chimera virus expressing the O1 Campos structural proteins carrying, among others aa substitutions, R56 in VP3 and demonstrated that this virus exhibited a small plaque phenotype in cells and was highly attenuated in bovines. These authors suggested that adaptation of type O1 viruses to cell culture results in the ability of the virus to utilize heparin sulfate (Jackson et al., 1996) as a receptor with a concomitant loss in virulence. In view of this data, Rodriguez-Pulido et al. (Rodriguez Pulido et al., 2009 ) introduced an R56H substitution in VP3 of an O1 Kaufbueren infectious cDNA clone (pO1K) to induce reversion of an attenuated phenotype. However, RNA transcripts derived from pO1K containing H56 did not exhibit differences in virulence in suckling mice compared to RNA transcripts carrying R56, indicating that the substitution itself was not sufficient to revert to the attenuated phenotype . It should be noted that no complete genomic sequence was determined for the viruses constructed in these previous works, so it is possible that additional residue substitutions may have affected these results.
Among the FMDV subtype O1 genomic sequences reported to GenBank, only the amino acids R or H are found in position 56 of VP3; however, the passage history of these viruses is unclear. Furthermore, there are no pathogenicity studies using viruses containing these sequences. The O/JPN/2000 strain isolated in the 2000 Japan outbreak exhibited a mild pathogenicity in bovines, and two different viral plaque phenotypes of this strain appeared after two passages in primary bovine cells. Genomic sequencing of the structural proteins revealed two aa substitutions (VP2 D133N and VP3 H56R) in the mildly pathogenic small plaque virus when compared to the large plaque virus in suckling mice (Kanno et al., 2002; Morioka et al., 2008) . Nevertheless, these two mutations did not account for the characteristics of another PanAsia strain isolated from China (Bai et al., 2010) . This study demonstrated that the BHK-21 cell-adapted O/Fujian/CHA/5/99 strain had high virulence in suckling mice and formed larger plaques than the bovine-isolated O/Tibet/CHA/1/99, while sequence analysis revealed that both strains carried a D residue in position 133 of VP2 and an H in position 56 of VP3.
To clarify the role of these amino acids in FMDV virulence, we mutated the aa at position 56 of VP3 in a full-length infectious cDNA clone derived from the FMDV O1 Campos/Bra/58 strain and evaluated the biological properties and virulence of these viruses in swine and cattle. Our results demonstrate that identical viruses differing only in aa residue 56 of VP3, H56 (O1Ca-VP3-56H) or R56 (O1Ca-VP3-56R), had similar growth kinetics in BHK-21 and LF-BK cells and slight differences in plaque size in BHK-21, LF-BK, IBRS-2 and LK cells. In contrast, the viruses displayed very different pathogenicities in two natural host species. Virus O1Ca-VP3-56H induced typical clinical signs of FMD in swine and cattle, whereas virus O1Ca-VP3-56R was innocuous unless it reverted to either H or cysteine (C) at VP3-56 during the animal infection. These results clearly demonstrate that the presence of R56 in VP3 is associated with virus attenuation during infections in natural host animals.
Results

Generation and characterization of pO1Ca
The full-length cDNA clone pO1Ca was constructed by overlapping PCR fragments flanked by unique restriction enzymes as described in Materials and methods and shown schematically in Fig. 1A . The fulllength cDNA was preceded by the T7 polymerase promoter and two additional G residues to improve transcription efficiency (Rieder et al., 1993) and followed by a polyA tail of 15 residues and a unique EcoRV site. Plasmid containing the substitution H56R in VP3 derived from the infectious clone pO1Ca was constructed as described in Materials and methods. (Pereda et al., 2002) ) showing the polyC tail (Cn) and the polyA (An) tail at the end of the 3′ untranslated region (UTR). The boxes below the genome represent the RT-PCR fragments used for the generation of the full-length cDNA clone (named pO1Ca) including the restriction sites used in the cloning strategy. A T7 RNA polymerase promoter was added at the 5′ end of the viral cDNA as well as a unique EcoRV site at the 3′ end to allow the synthesis of RNA transcripts. Restriction site EcoRI is also indicated. The mutations at position 2713 CAT → CGC resulting in the substitution of aa H by R at position 56 of VP3 are indicated. (B) RNAs derived from in vitro transcription of pO1Ca digested with selected enzymes were translated in a rabbit reticulocyte system and the products were then analyzed by PAGE on a 15% gel. To check the ability of pO1Ca to function as a template for protein synthesis, RNA transcripts derived from EcoRV-linearized plasmid were translated in vitro using reticulocyte lysates as described by Piccone et al. (1995) . To facilitate the identification of the viral proteins, pO1Ca was digested with selected restriction enzymes that remove the downstream portion of the viral genome from the plasmid facilitating the interpretation of the viral protein pattern using SDS-PAGE. Fig. 1B shows that the polyprotein derived from transcripts of pO1Ca was processed into the virus precursors and mature proteins, indicating its ability to undergo viral proteolytic processing.
In vitro characterization of the infectious clone-derived viruses
RNA transcript derived from pO1Ca-VP3-56H or pO1Ca-VP3-56R was used to transfect BHK-21 cells by electroporation, and then supernatant from transfected cells was subjected to serial passage in LF-BK αVβ6 cells to amplify the clone-derived viruses. Sequencing of the entire genome of recovered viruses (O1Ca-VP3-56H and O1Ca-VP3-56R) verified that they were identical to the parental DNAs, confirming that only the predicted mutations were incorporated into the viruses. Sequencing results also revealed that nt changes in the third position of codons 55 and 57 (flanking position 56) of VP3 introduced during the construction of pO1Ca-VP3-56R were retained (data not shown), excluding the possibility of contamination by the parental virus.
The in vitro growth characteristics of viruses O1Ca-VP3-56H and O1Ca-VP3-56R were comparatively evaluated in multi-step growth curves in BHK-21 and LF-BK cells. Cells were infected at a low (0.01) or high (10) MOI and samples were collected at times post-infection through 24 h. The results shown in Fig. 2A demonstrate that both viruses exhibited similar growth characteristics and reached comparable titers in these cell lines. Additionally, the plaque size and morphology of these viruses was analyzed in a standard plaque assay in cells from different origins (Fig. 2B ). Both viruses produced a similar plaque size in BHK-21 cells, while virus O1Ca-VP3-56R produced smaller plaques compared to O1Ca-VP3-56H in IBRS-2 and LF-BK cells, but clearly larger plaques compared to O1Ca-VP3-56H in LK cells.
Virulence assessment of FMDV O1Ca-VP3-56H and O1Ca-VP3-56R in cattle
Virulence of both viruses in cattle was assessed utilizing a well established intradermolingual inoculation method (Henderson, 1949) . Two cows were inoculated with 10 4 PFU/animal of either O1Ca-VP3-56H or O1Ca-VP3-56R, and infection and clinical signs were monitored daily as described by Pacheco and Mason (2010) . Results demonstrated that the two animals inoculated with the O1Ca-VP3-56H strain (#42 and #43) developed clinical FMD and reached the maximum clinical score (4 feet affected with vesicles) by 2 or 3 days post-inoculation (dpi). Both animals displayed fever (N40°C) from 2 to 4 or to 6 dpi. Viremia lasted 4 to 5 days, starting at 1 dpi. Virus shedding was detected in nasal swabs from both animals beginning at 1 dpi to the end of the collection period (7 dpi) (Fig. 3) . Sequence analysis of the P1 polyprotein confirmed that viruses collected from secondary replication sites exhibited no differences from the inoculated virus (data not shown). Interestingly, cows inoculated with O1Ca-VP3-56R (#44 and #45) showed no clinical signs, no fever, no viremia and no virus shedding (Fig. 3) . Additionally, no serum neutralizing antibodies were detected 2 months after inoculation, no virus was isolated from probangs and no transmission occurred to two cows that were in direct contact since 1 dpi (results not shown). These results suggest that O1Ca-VP3-56R does not undergo any detectable replication when inoculated into animals.
Virulence assessment of FMDV O1Ca-VP3-56H and O1Ca-VP3-56R in swine
To examine the effect of H and R amino acids at position 56 of VP3 on virus virulence in pigs, six animals were intradermally inoculated with approximately 10 4 PFU/animal of either O1Ca-VP3-56H or O1Ca-VP3-56R (Figs. 4 and 5, respectively) and monitored for clinical disease. All animals infected with O1Ca-VP3-56H (#01 through #06) developed classic FMD disease. Animals became febrile, depressed, lame and developed lesions in the non-inoculated feet and mouth. By the second week post-inoculation, the disease had subsided and animals were returning to their normal physiological state. Presence of viremia, detected by real-time RT-PCR, demonstrated the presence of virus in blood starting on the first day of disease peaking by day 2 to 3. Virus was also detected by rRT-PCR in nasal swabs of all 6 animals starting as early as 2 dpi and peaking at 2 to 4 dpi. Conversely, the six animals inoculated with O1Ca-VP3-56R (#07 through #12) presented a heterogeneous phenotype. Two of the animals (#11 and #12) did not display any FMD-related symptoms, presenting as clinically normal throughout the entire experimental period. Accordingly, no virus could be detected in the blood or nasal swabs of these animals at any test time points. Conversely, the other four animals inoculated with O1Ca-VP3-56R presented a disease that was nearly indistinguishable in intensity compared to that observed in animals infected with O1Ca-VP3-56H, differing only by a slight delay in the course of the disease (approximately by 1-3 days). Consequently, in these four animals viremia kinetics was also delayed by a similar lag of time in relation to the appearance of clinical symptoms (Fig. 5) . Partial RNA sequencing of the viruses isolated from animals was performed to evaluate the genetic stability of the inoculated virus during the infection in vivo. All virus isolates from local lesions in animals inoculated with O1Ca-VP3-56H presented an H at position 56 of VP3. As mentioned earlier, no virus was isolated from animals infected with O1Ca-VP3-56R that did not develop disease. Interestingly, all viruses isolated from the four symptomatic animals infected with O1Ca-VP3-56R possessed a mutation at position 56 of VP3; in three of them R was substituted by H and in the fourth case by C (data not shown). The above results indicate that animals inoculated with O1Ca-VP3-56R remain asymptomatic unless R at position 56 mutates to either an H or a C.
Effect of R at position 56 of VP3 on thermal stability
Since temperature sensitivity has been linked with attenuation phenotype for FMDV (Butrapet et al., 2000; Omata et al., 1986) , viruses O1Ca-VP3-56H and O1Ca-VP3-56R were analyzed for their ability to produce plaques at 41°C, a non-permissive temperature. Using ten-fold dilutions of the virus stocks, plaque assays were performed at low MOI and, after adsorption at 37°C, cells were incubated at either 37°C or 41°C for 48 h. While virus O1Ca-VP3-56H displayed a slight reduction in the number of plaques at 41°C regarding those detected at 37°C, virus O1Ca-VP3-56R failed to produce plaques in LF-BK cells at all dilutions tested (between 10 −2 and 10
) (data not shown). To further characterize the effect of temperature on the viruses' growth, LF-BK cells were infected at a high MOI (MOI = 10) and incubated at 41°C. Both viruses achieved lower titers at all tested time points at 41°C compared to 37°C (Fig. 2A) . In addition, virus O1Ca-VP3-56R grew slower than virus O1Ca-VP3-56H but reached similar final yield, indicating that the substitution H56R had no significant effect on virus production.
To further test the temperature sensitivity of these viruses, samples were heated up to 24 h at either 37°C or 41°C and aliquots were taken at different time points during the heat treatment and titrated on LF-BK cells. Infectivity titers of FMDV O1Ca-VP3-56R virus were strongly reduced at both temperatures when compared with O1Ca-VP3-56H. An approximately 4 logs reduction titer was observed after heating for 8 h at 37°C or after 4 h at 41°C (Fig. 6) . Moreover, to determine if H56 confers a better fitness to the viral population at a higher temperature, a serial passage experiment was performed in LF-BK cells at 41°C with these viruses. Sequencing analysis revealed that after and #43) or O1Ca-VP3-56R SK6 (animal #44 and #45). Presence of clinical signs (clinical scores), rise in body temperature over 40°C (+), and virus yield (quantified as log 10 of viral RNA copies/ml of sample) in blood and nasal swabs were daily determined during a seven day observational period.
three passages virus O1Ca-VP3-56R acquired an H codon at position 56, whereas virus O1Ca-VP3-56H conserved the original sequence (Table 1) . The presented results indicate that the H56R substitution in VP3 drastically reduces the thermal stability of the virus.
Discussion
Previous works have suggested that the H56R substitution is acquired during the process of virus adaptation to cell cultures, conferring an attenuated phenotype in mice and bovines with an increased affinity for heparin Jackson et al., 1996; Jensen and Moore, 1993; Rodriguez Pulido et al., 2009; Sa-Carvalho et al., 1997) . In fact, R56 of VP3 is the critical viral residue used for recognition of the cellular heparin sulfate (HS) co-receptor by different strains of FMDV, as seen in the structure of the serotype O1BFS in complex with various glycosaminoglycans (Fry et al., 1999) . Nevertheless, none of these studies have assayed the infectivity of type O transcripts or viruses exclusively differing in the aa residue at position 56 of VP3 (either H or R) in the natural host. The purpose of this study was to experimentally demonstrate the role of each of these amino acids in this particular position on viral virulence in the natural host. To this end, recombinant viruses were created by modifying a full-length infectious cDNA clone of the O1 Campos/ Bra/58 strain to introduce either H or R at VP3-56. Viruses O1Ca-VP3-56H and O1Ca-VP3-56R recovered after electroporation of BHK-21 cells showed similar growth kinetics and small differences in plaque sizes in cell culture. In contrast, these viruses displayed a marked difference in thermal inactivation at 41°C. In vitro heating of the viruses caused a pronounced loss of infectivity for virus O1Ca-VP3-56R compared to O1Ca-VP3-56H, suggesting a role for the aa at VP3-56 in the thermal stability of the virion. At this temperature, plaque assays also showed significant differences between both viruses at higher dilutions, although at MOI 10 they replicate to similar titers. These results suggest that the substitution H56R may affect the capsid assembly or stability of the virion. Amino acid 56 of VP3 is a surface partially exposed residue, which also participates in interactions with VP1 and VP2 residues that stabilize the FMDV protomer (Fig. 7A ). Hence, having an H instead of an R at this position may affect such interactions (Fig. 7B, C) . Further experiments are necessary to validate this assumption. In any case, H56 likely increased the thermal stability of the virus, since after two passages of O1Ca-VP3-56R in cell culture at 41°C VP3-R56 changed to VP3-H56. On the other hand, the identification of aa that increase the thermal stability of the virion without disrupting its infectivity could support the rational engineering of FMD vaccines (Mateo et al., 2003 (Mateo et al., , 2008 .
Another major difference between O1Ca-VP3-56H and O1Ca-VP3-56R relates to their ability to cause disease in the natural host. Principally, cattle inoculated with O1Ca-VP3-56H showed typical clinical signs of FMD, while cattle inoculated with O1Ca-VP3-56R did not display any clinical signs of disease. Furthermore, no neutralizing antibodies or virus in blood or saliva was detected in animals inoculated with O1Ca-VP3-56R. Since both viruses differ only in the aa at position 56 of VP3, this data clearly indicates that the presence of R56 is responsible for the attenuation of O1Ca-VP3-56R in cattle. Additionally, the virulence of both viruses was tested in swine. All animals inoculated with O1Ca-VP3-56H exhibited clinical signs of FMD while those inoculated with O1Ca-VP3-56R remained clinically normal with the exception of some animals that developed delayed FMD. Interestingly, the virus recovered from lesions in these animals had a R56C or R56H mutation and no other mutations in their protein coding region, confirming the involvement of R56 in viral attenuation. Similar VP3 R to H or C substitutions were previously reported by Sa-Carvalho et al. (1997) in A24/O1 Campos chimeric viruses recovered from infected cattle, although additional substitutions accompanied that at position 56 of VP3. Presence of clinical signs (clinical scores), rise in body temperature over 40°C (+), and virus yield (quantified as log 10 of viral RNA copies/ml of sample) in blood and nasal swabs were daily determined during a seven day observational period.
As seen in Fig. 7 , residue 56 is located at the interface between VP2 and VP3 proteins, in close contact with the C-terminus of VP1, near the icosahedral three-fold axis. Structural comparisons between O1BFS and O1K, having R and H in position 56 of VP3, respectively, demonstrated important changes at the capsid surface between the two strains (Lea et al., 1995) . These changes may explain the different properties exhibited by viruses carrying R or H in VP3-56 such as reactivity with MAbs (Kitson et al., 1990; Sa-Carvalho et al., 1997) or thermal stability properties. Additional studies with subtype O1 viruses have shown that R56 of VP3 increases the positive charge of the viral surface at this site and strongly enhances binding to negatively charged HS (Fry et al., 1999; Jackson et al., 1996) . Fry et al. (1999) hypothesized that the high affinity to HS presumably hampers the spread of infection by sequestering viruses from the target cells/tissues. Consistent with this hypothesis, a virus carrying R56 cannot develop virulent infections in vivo unless it undergoes a reversion to H or C, reducing HS affinity.
Materials and methods
Cell lines and virus
Baby hamster kidney (BHK-21) cells, secondary lamb kidney (LK) cells, bovine kidney (LF-BK) cells (Swaney, 1988 ) and a derivative LF-BK cell line expressing the bovine αVβ6 integrin (LF-BK αVβ6) (LaRocco et al., unpublished data) were maintained as previously described (Piccone et al., 2010) . Growth kinetics and plaque assays Fig. 6 . Temperature sensitivity of O1Ca-VP3-56H and O1Ca-VP3-56R viruses. Virus stocks were heated up to 24 h at either 37°C or 41°C and aliquots were taken at different times during the heat treatment and titrated on LF-BK cells. Infectivity titers are expressed in TCID 50 /ml. Threshold of detection is log 10 1.80 TCID 50 /ml.
Table 1
Sequence comparison around the position VP3-56 between O1Ca-VP3-56H and O1Ca-VP3-viruses amplified at different temperatures.
O1Ca-VP3-56H
O1Ca-VP3-56R
Virus stocks were passaged three times in LF-BK cells at MOI 10 and the temperature indicated. Changes in nucleotides and amino acid sequence are compared with original virus (Passage 0). Presence of clinical signs (clinical scores), rise in body temperature over 40°C (+), and virus yield (quantified as log 10 of viral RNA copies/ml of sample) in blood and nasal swabs were daily determined during a seven day observational period.
were performed also as described previously (Piccone et al., 1995) . The FMDV strain O1Campos/Bra/58 was obtained from the Institute of Virology at the National Agricultural Technology Institute, Argentina.
Construction of the FMDV O1 Ca full-length cDNA clone and derivative
Total RNA from FMDV-infected BHK-21 cells was isolated with the TRIzol® system (Life-Technologies), and reverse transcribed by standard methods using random hexamers (PROMEGA) and SuperScript II reverse transcriptase (Life-Technologies). cDNA fragments were amplified with the Expand High Fidelity PCR system (Roche Applied Science, Indianapolis, IN) using primers on unique restriction sites naturally found in the FMDV O1Campos/Bra/58 sequence. All nucleotide numbering included in this study refers to the sequence deposited in GenBank under accession number AJ320488.
A total of 4 fragments covering the complete viral genome were amplified (Fig. 1A) . The 3′ and 5′ ends of the viral genome as well as the introduction of the polyC tail were obtained by a RACE-PCR technique. For the 3′ end, a 40mer primer (5′GAATTCCATATGgatatcT 15 GATTAAG3′) complementary to the 3′ end of the viral genome, including 15 adenine residues, followed by an adaptor sequence containing an EcoRV site (lower case) was used for priming the cDNA synthesis. Thereafter, PCR was performed using sense primer nt 5416-5′ GGCAGCAATTgaattcTTT3′ on a unique EcoRI site (lower case) and antisense primer 5′GAATTCCATATGgatatc3′ complementary to the adaptor sequence.
For the 5′ end, PCR was performed using sense primer 5′ GGAATTCcatagTAATACGACTCACTATAGGTTGAAAGGGGGCGCTAGGC3′, which contained the sequences of a NdeI site (lower case), T7 promoter (underlined), two additional G nucleotides (bold) and 19 nucleotides of the 5′ end of the viral genome; and antisense primer nt 350-5′TTggatccTGAAAGGCGGGCGTCGGG3′ which incorporated a StyI site (lower case). To add the polyC tail, the PCR reaction was carried out using sense primer 5′ TtcctaggC 17 TAGGTTTTACCGTCATTCCC which contained a StyI site (lower case) and antisense primer nt 3019-5′CAGTGCgcggccgcCTCAGGTGTC3′ on a unique NotI site (lower case).
All purified PCR products were cloned into the pGEM-T easy vector (Promega) and sequenced using selected primers. The assembly of the full-length cDNA clone was done using a multi-step strategy that implemented the unique restriction sites NdeI, StyI, NotI, EcoRI and EcoRV on pGEM vectors. Each step of the construction was monitored by restriction enzyme analysis to ensure the generation of fragments of predicted sizes. The final plasmid containing the genome-length cDNA of FMDV O1Campos/Bra/58 was designated as pO1Ca and completely sequenced using an Applied Biosystems 3730 xl automated DNA sequencer (Applied Biosystems, Foster City, CA).
Substitution of aa H56 in the structural protein VP3 was carried out by site-directed mutagenesis in plasmid pO1Ca using the QuickChange system (Stratagene) and forward primer nt 2695-5′ GGCATGCCCGACGTTTCTGCGCTTCGAGGGT GGCGTACCGTAC3′ containing the desired change (in bold), following the manufacturer's protocol. The full-length mutant clone was completely sequenced to confirm the presence of expected modifications and absence of unwanted substitutions.
Transfection and recovery of the infectious clone-derived viruses
Plasmid pO1Ca or its mutant version was linearized at the EcoRV site following the poly(A) tract and used as a template for RNA synthesis using the MegaScript T7 kit (Ambion, Austin, TX), according to the manufacturer's protocols. BHK-21 cells were transfected with these synthetic RNAs by electroporation (Electrocell Manipulator 600; BTX, San Diego, CA) as previously described (Mason et al., 1994) . Briefly, 0.5 ml of BHK-21 cells at a concentration of 1.5 × 10 7 cells/ml in phosphate-buffered saline (PBS) were mixed with 10 μg of RNA in a 4-mm-gap BTX cuvette. The cells were then pulsed once at 330 V, infinite resistance, and a capacitance of 1000 μF; diluted in cell growth medium and allowed to attach to a T-25 flask. After 4 h, the medium was removed, fresh medium was added and the cultures were incubated at 37°C for up to 24 h. The supernatants from transfected cells were passed in LF-BK αVβ6 cells until a cytopathic effect (CPE) appeared. After successive passages in these cells, virus stocks were prepared and the viral genome completely sequenced using the Prism 3730xl automated DNA sequencer (Applied Biosystems), as previously described (Piccone et al., 2010) .
Viruses derived from plasmid pO1Ca and the derived mutant plasmid encoding the aa substitution H56R in VP3 are referred to in this work as O1Ca-VP3-56H and O1Ca-VP3-56R, respectively.
In vitro processing
Plasmid pO1Ca containing the complete genome sequence was linearized with EcoRV and in vitro transcribed using the T7-based MegaScript kit (Ambion, Inc., Austin, Tex.). RNA transcripts were translated in vitro by using rabbit reticulocyte lysates (Promega, Fitchburg, WI) in the presence of [
35 S] methionine and translation reaction mixtures were resolved by electrophoresis on 15% polyacrylamide gels containing sodium dodecyl sulfate (SDS-PAGE) and fluorographed, following previously described procedures (Piccone et al., 1995) . Additionally, pO1Ca was digested with selected restriction enzymes that eliminate part of the viral open reading frame, and used in in vitro transcription/translation assays Virulence of O1Ca-VP3-56H or O1Ca-VP3-56R viruses in cattle and swine
Animal experiments were performed under biosafety level 3 conditions in the animal facilities at PIADC following a protocol approved by the Institutional Animal Care and Use Committee. Two steers (300-400 kg) were infected per the intradermolingual inoculation method (Henderson, 1949) with approximately 10 4 PFU/cattle of FMDV O1Ca-VP3-56H or O1Ca-VP3-56R, diluted in MEM. Six pigs (20 kg) were infected intradermally (Pacheco and Mason, 2010) with 10 4 PFU/pig of either FMDV O1Ca-VP3-56H or O1Ca-VP3-56R, diluted in MEM. For 7 days after inoculation, animals were clinically examined, including rectal temperature recordings and serum and nasal swabs collection. After collection, clinical samples were aliquotted and frozen at −70°C. One serum and one swab aliquot were used to perform viral titration by rRT-PCR as described previously . For cattle, clinical scoring was made based on lesions present in each foot, with a maximum of 4. For swine, the clinical score was based on severity of affected digits and/or snout, as previously described (Pacheco and Mason, 2010) , with a maximum of 20.
